Eeva Sipila appointed Metso's CFO
Feb 03, 2016 12:38 pm UTC| Business
HELSINKI, Finland, Feb. 3, 2016 -- Eeva Sipil, M.Sc. (Econ.), CEFA, has been appointed Metso's Chief Financial Officer (CFO) starting August 1, 2016. Eeva Sipil will be a member of Metso's Executive Team and will report...
EarthLink Declares Quarterly Dividend of $0.05 Per Share
Feb 03, 2016 12:30 pm UTC| Business
ATLANTA, Feb. 03, 2016 -- EarthLink (EarthLink Holdings Corp.)(NASDAQ:ELNK) today announced that its Board of Directors declared a quarterly cash dividend on its common stock in the amount of $0.05 per share to be paid...
Icahn Enterprises Announces Expiration of Cash Tender Offer for Shares of Pep Boys
Feb 03, 2016 12:30 pm UTC| Business
NEW YORK, Feb. 03, 2016 -- Icahn Enterprises L.P. (“Icahn Enterprises”) (NASDAQ:IEP) today announced that the tender offer of Icahn Enterprises Holdings L.P. and its wholly owned subsidiary, IEP Parts Acquisition LLC...
CDK Global Reports Second Quarter Fiscal 2016 Results
Feb 03, 2016 12:30 pm UTC| Business
GAAP Revenues Rise 1%; Adjusted Revenues Rise 3%, 6% on a Constant Currency BasisGAAP Net Earnings Increase 61%; Adjusted Net Earnings Increase 23%Fiscal 2016 Forecast is in-line with Prior Forecast Despite Certain Items...
TG Therapeutics, Inc. to Present at the 18th Annual BIO CEO & Investor Conference
Feb 03, 2016 12:30 pm UTC| Business
NEW YORK, Feb. 03, 2016 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that Michael S. Weiss, the Company’s Executive Chairman and Interim Chief Executive Officer, will present at the 18th Annual BIO CEO ...
FDA Grants Conatus Fast Track Designation for Development of Emricasan in NASH Cirrhosis
Feb 03, 2016 12:30 pm UTC| Business
SAN DIEGO, Feb. 03, 2016 -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the company’s emricasan development program...
Cempra to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Feb 03, 2016 12:30 pm UTC| Business
CHAPEL HILL, N.C., Feb. 03, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,...